Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Cancer Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888648
What this trial is testing

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Cancer Non-resectable
Zhejiang University 30
Very early researchActive Not RecruitingNCT06765876
What this trial is testing

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Who this might be right for
Leukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)+1 more
Institute of Hematology and Blood Transfusion, Czech Republic 18
Not applicableLooking for participantsNCT05582876
What this trial is testing

Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Bialystok 366
Early research (Phase 1)Active Not RecruitingNCT07485569
What this trial is testing

Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

Who this might be right for
Thyroid Cancer Stage IVAnaplastic Thyroid CancerDifferentiated Thyroid Cancer+1 more
Radboud University Medical Center 10
Not applicableLooking for participantsNCT03962920
What this trial is testing

Personalized Treatment of Urogenital Cancers Depends on the Microbiome

Who this might be right for
Microbial Disease
Zealand University Hospital 28
Not applicableUnknownNCT01641679
What this trial is testing

PET Evaluation of Recurrent Differentiated Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsDifferentiated Thyroid Cancer
The Netherlands Cancer Institute 100
Not applicableLooking for participantsNCT05830279
What this trial is testing

Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer

Who this might be right for
Nausea With Vomiting Chemotherapy-InducedDepression, ReactiveCancer Pain
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 600
Testing effectiveness (Phase 2)Study completedNCT01003964
What this trial is testing

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
National Cancer Center, Korea 289
Early research (Phase 1)Ended earlyNCT02780128
What this trial is testing

Next Generation Personalized Neuroblastoma Therapy

Who this might be right for
NeuroblastomaCancer
Yael P Mosse 66
Not applicableStudy completedNCT04693364
What this trial is testing

Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment

Who this might be right for
Breast Carcinoma
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT03131089
What this trial is testing

Young Breast Cancer Cohort Study

Who this might be right for
Breast Cancer
Samsung Medical Center 2,000
Not applicableStudy completedNCT03460483
What this trial is testing

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

Who this might be right for
Endometrial AdenocarcinomaEndometrial CarcinomaLynch Syndrome+1 more
Ohio State University Comprehensive Cancer Center 1,001
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Not applicableLooking for participantsNCT07380971
What this trial is testing

Developing a Comprehensive Exercise Service for Breast Cancer Process

Who this might be right for
Breast Cancer
GO fit Lab- Ingesport 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02299999
What this trial is testing

SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
UNICANCER 1,460
Not applicableLooking for participantsNCT06725576
What this trial is testing

Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma

Who this might be right for
Thyroid Cancer, Papillary
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 201
Early research (Phase 1)Study completedNCT02709616
What this trial is testing

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Who this might be right for
Glioblastoma
Guangdong 999 Brain Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT07269626
What this trial is testing

PULSAR in Systemic Therapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma
Samsung Medical Center 47
Not applicableNot Yet RecruitingNCT05373251
What this trial is testing

PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
British Columbia Cancer Agency 500
Not applicableStudy completedNCT05045573
What this trial is testing

Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Montpellier 28
Next Page